Cardiopulmonary bypass and the inflammatory response: A role for serine protease inhibitors?
- 1 April 1997
- journal article
- review article
- Published by Elsevier in Journal of Cardiothoracic and Vascular Anesthesia
- Vol. 11 (2) , 19-23
- https://doi.org/10.1016/s1053-0770(97)80006-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Aprotinin therapy in cardiac operations: A report on use in 41 cardiac centers in the United KingdomThe Annals of Thoracic Surgery, 1993
- The role of bradykinin in mediating ischemic brain edema in rats.Stroke, 1993
- DOES APROTININ INHIBIT CARDIOPULMONARY BYPASSINDUCED INFLAMMATION?Anesthesiology, 1992
- Effect of aprotinin on neutrophil function after major vascular surgeryBritish Journal of Surgery, 1992
- Therapeutic Trial of Cerebral Vasospasm with the Serine Protease Inhibitor, FUT-175, Administered in the Acute Stage after Subarachnoid HemorrhageNeurosurgery, 1992
- Preventive Effect of Synthetic Serine Protease Inhibitor, FUT-175, on Cerebral Vasospasm in RabbitsNeurosurgery, 1992
- Platelet and neutrophil activation in cardiopulmonary bypassThe Annals of Thoracic Surgery, 1990
- Clinical Application of Inhibitors of FibrinolysisDrugs, 1985
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Effect of the Kallikrein Inhibitor Aprotinin on Myocardial Ischemia and Necrosis in ManAngiology, 1980